Research Article
Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture
Table 4
(a) CIPN perceived symptom severity (NRS) day 21–day 0 and day 84–day 0; (b) NRS—subjective CIPN complaints (ANCOVA day 21).
(a) |
| Group | Day | Mean ± SD | Diff. mean day 21–day 0 day 84–day 0 |
| EA () | 0 | | | 21 | | −0.8 | 84 | | −0.6 |
| HB () | 0 | | | 21 | | −1.7 | 84 | | −0.8 |
| VitB () | 0 | | | 21 | | −1.6 | 84 | | −1.8 |
| Placebo () | 0 | | | 21 | | −1.3 | 84 | | −1.8 |
|
|
(b) |
| | Difference | 95% CI | One-sided t-test | Two-sided t-test |
| EA versus placebo | 0.3 | −0.8–1.4 | | | HB versus placebo | −0.2 | −1.3–0.9 | | | EA versus VitB | 0.5 | −0.6–1.7 | | | HB versus VitB | 0.0 | −1.1–1.2 | | | EA versus HB | 0.2 | −0.9–1.3 | | | VitB versus placebo | −0.2 | −1.3–0.8 | | |
|
|